Category: New products
-
Hydrogel Injection Tested to Treat Advanced Artery Disease
9 March 2016. A biomedical engineering team developed an injected hydrogel for advanced cases of peripheral artery disease that in lab animals improved blood flow and muscles in affected limbs. Researchers from University of California in San Diego, led by bioengineering professor Karen Christman, published their findings earlier this year in the Journal of the…
-
Genetics Company Makes Available Cancer Sequencing Database
8 March 2016. A genetic testing company is making freely available a database of genomic sequencing data from patients with breast and ovarian cancer. The database, from 10,000 human genomes but with personal identity removed, is offered by Ambry Genetics in Aliso Viejo, California. Ambry Genetics is a 16 year-old company offering genetic tests for…
-
Platform Devised for 3-D Engineered Heart, Liver Tissue
8 March 2016. An engineering team at University of Toronto designed and tested in lab animals a technology for growing synthetic heart and liver tissue for drug testing and eventual clinical use. Researchers led by chemical engineering professor Milica Radisic published their findings yesterday (7 March) in the journal Nature Materials; paid subscription required. Radisic…
-
Allergy Drug Shown to Allow Eating Small Peanut Amounts
7 March 2016. A new drug was shown in a clinical trial to allow most children and teens with food allergies to eat peanuts in small quantities. The results of the intermediate-stage trial were reported yesterday at the annual meeting of American Academy of Allergy, Asthma and Immunology in Los Angeles. Allergies to peanuts and other…
-
Gene Editing Creates Pigs Resilient to African Virus
23 February 2016. University and industry researchers edited the genomes of domesticated pigs to create a variety better able to withstand a deadly tick-borne virus. The team from University of Edinburgh and the biotechnology companies Sangamo BioSciences and Genus plc published its findings in yesterday’s (22 February) issue of the journal Scientific Reports. The team…
-
Duchenne-Related Stem Cell Heart Therapy Trial Underway
22 February 2016. An early clinical trial testing a stem cell therapy for heart disease among individuals with Duchenne muscular dystrophy treated its first enrolled patient. The trial is conducted by Capricor Inc. in Los Angeles, developer of the treatments code-named CAP-1002, for cardiomyopathy or heart failure related to Duchenne muscular dystrophy. Duchenne muscular dystrophy is…
-
Pain Medication Given FDA Breakthrough Tag
22 February 2016. A new drug to treat moderate to severe pain, now in clinical trials, received a breakthrough designation from the U.S. Food and Drug Administration. The drug, oliceridine, is made by Trevena Inc. in King of Prussia, Pennsylvania. Oliceridine addresses the same pain signals as opioid drugs that affect areas of the brain…
-
Antibody Treatment Designed for MERS Virus
18 February 2016. The Middle East respiratory syndrome coronavirus, or MERS virus, is spreading throughout the Middle East and Asia, largely through person-to-person contacts, and with a fatality rate of 36 percent. A research team at University of Maryland, with colleagues from industry and government labs, developed antibodies from genetically-engineered cattle that protect lab mice…
-
Vaccine Developed to Stop Synthetic Opioids
17 February 2016. Fentanyl is a synthetic opioid drug for treating severe pain after surgery, and in some cases chronic pain, but is also highly addictive and increasingly abused, with growing numbers of overdose deaths. Researchers from Scripps Research Institute in La Jolla, California developed a vaccine that in lab mice prevents ingredients in fentanyl…
-
Company Hosts Cancer Genome Cloud, Raises $45 Million
16 February 2016. Seven Bridges Genomics, a computational biology company, unveiled its cloud-based cancer genome data sets, in one of three pilot tests for National Cancer Institute. The Cambridge, Massachusetts enterprise also raised $45 million in its first venture funding round. National Cancer Institute, part of National Institutes of Health, aims to make the Cancer…